Patents by Inventor Adam Joseph Dixon

Adam Joseph Dixon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220122486
    Abstract: An ultrasound training model which exhibits optically clear soft tissue-mimicking materials that are simultaneously acoustically scattering and self-healing to needle punctures. An exemplary embodiment is disclosed that comprises an embedded bone-mimicking spine model and a dual-purpose lid that may be used as a friction surface mat. Various embodiments of the training model materials are disclosed.
    Type: Application
    Filed: October 14, 2021
    Publication date: April 21, 2022
    Applicant: Rivanna Medical LLC
    Inventors: Adam Joseph Dixon, Frank William Mauldin, JR.
  • Patent number: 10893881
    Abstract: Systems and methods for treating a blood clot include a catheter to be inserted into a patient. The catheter is used to deliver low stability microbubbles toward the blood clot in the patient. A thrombolytic agent is delivered toward the blood clot, and ultrasonic energy is applied to the microbubbles to vibrate the microbubbles.
    Type: Grant
    Filed: August 28, 2015
    Date of Patent: January 19, 2021
    Assignee: University of Virginia Patent Foundation
    Inventors: Adam Joseph Dixon, John Alexander Hossack
  • Publication number: 20180099059
    Abstract: A composition for cell tracking and molecular imaging containing perfluorocarbon (“PFC”) droplets having a liquid PFC core enclosed within a stabilizing shell and embedded with solid nanoparticles. The solid nanoparticles act as nucleating agents for reducing the activation pressure of the liquid PFC core required to transition the liquid PFC core to a gaseous microbubble thereby permitting the use of more body-temperature stable longer chain PFCs in the liquid PFC core. The improved stability of the PFC droplets with a reduced or limited increase in the activation pressure required due to the nucleating nanoparticles improves the efficacy of using the PFC droplets as phase-change contrast agents.
    Type: Application
    Filed: October 10, 2017
    Publication date: April 12, 2018
    Inventors: John A. Hossack, Adam Joseph Dixon, Edwin Lu
  • Patent number: 9895158
    Abstract: Systems and methods for treating a blood clot include a catheter to be inserted into a patient. The catheter is used to deliver low stability microbubbles toward the blood clot in the patient. A thrombolytic agent is delivered toward the blood clot, and ultrasonic energy is applied to the microbubbles to vibrate the microbubbles.
    Type: Grant
    Filed: June 10, 2015
    Date of Patent: February 20, 2018
    Assignee: University of Virginia Patent Foundation
    Inventors: Adam Joseph Dixon, John Alexander Hossack
  • Publication number: 20170360460
    Abstract: Systems and methods for treating a blood clot include a catheter to be inserted into a patient. The catheter is used to deliver low stability microbubbles toward the blood clot in the patient. A thrombolytic agent is delivered toward the blood clot, and ultrasonic energy is applied to the microbubbles to vibrate the microbubbles.
    Type: Application
    Filed: June 10, 2015
    Publication date: December 21, 2017
    Inventors: Adam Joseph Dixon, John Alexander Hossack
  • Publication number: 20170281130
    Abstract: Systems and methods for treating a blood clot include a catheter to be inserted into a patient. The catheter is used to deliver low stability microbubbles toward the blood clot in the patient. A thrombolytic agent is delivered toward the blood clot, and ultrasonic energy is applied to the microbubbles to vibrate the microbubbles.
    Type: Application
    Filed: August 28, 2015
    Publication date: October 5, 2017
    Inventors: Adam Joseph Dixon, John Alexander Hossack
  • Publication number: 20150272601
    Abstract: Systems and methods for treating a blood clot include a catheter to be inserted into a patient. The catheter is used to deliver low stability microbubbles toward the blood clot in the patient. A thrombolytic agent is delivered toward the blood clot, and ultrasonic energy is applied to the microbubbles to vibrate the microbubbles.
    Type: Application
    Filed: June 10, 2015
    Publication date: October 1, 2015
    Inventors: Adam Joseph Dixon, John Alexander Hossack